This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.
The benefits of utilizing AI in clinicalresearch Patient recruitment and diversity AI is increasingly being utilized in the recruitment process for clinical trials , aiming to connect individuals with potential benefits from investigational treatments.
This exclusive interview with Dr Sharon Benzeno, Chief Commercial Officer, Immune Medicine at Adaptive Biotechnologies, unveils some ground-breaking research on T- cell therapy for cancer , which has seen the first TCR-based therapeutic candidate progress to clinical development, offering promising advancements in innovative cancer treatments.
Developing treatments for individuals living with rare diseases is critical, but orphan drug development is laden with unique obstacles that necessitate innovative, multifaceted approaches. This limited pool poses significant barriers to conducting statistically significant studies and validating the efficacy and safety of new treatments.
Susceptibility or risk biomarkers can detect the likelihood of a patient developing a disease or medical condition, which is crucial for treatments that are most effective before the onset of symptoms. Diagnostic biomarkers typically confirm or establish a diagnosis and are often used in selecting patient populations for clinical trials.
The recent surge in GLP-1 treatments has ignited a profound shift in the pharmaceutical landscape, with more studies being announced than ever before. However, the treatment journey does not end with weight reduction, as maintaining weight loss overall is equally crucial.
For clinicalresearch professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. Additionally, consider the locations of your trial; if it is multiregional, you can start planning for your overall product approval strategy.
Molecular-level biochemical assays like transcriptomics, genomics and proteomics have emerged as valuable tools for identifying potential targets in cancer treatment through deep cyclic inhibition (DCI). How does the DCI mechanism compare to the design of other drugs for cancer treatment?
In the clinicalresearch space, GxP is a set of quality regulations and guidelines designed to establish the safety, efficacy, and integrity of pharmaceuticals, medical devices, and clinical trials. This blog explores key concepts, regulations, and the importance of GxP in delivering successful clinical trials.
In China, the high incidence of solid tumors is driving an urgent need for advanced therapies, spurring the push for new treatment approaches. There has also been an increase in government and regulatory support for CGT trials, in conjunction with an increase in investments for these products to get to market.
Despite its prevalence, there’s still a lot that people don’t understand about atopic dermatitis, its symptoms, and the treatment methods available to patients who suffer from the condition. Triggers can vary patient by patient, but some of the most common eczema triggers are: Cosmetic products. What Causes Atopic Dermatitis?
In preparation for World Orphan Drug Congress Europe, we interviewed Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, and Derek Ansel, MS, LCGC, Vice President, Therapeutic Strategy Lead, Rare Disease, to hear their insights into the current progress in rare disease research and their hopes for 2025.
Casgevy, the commercial product formerly known as exa-cel, is administered by taking stem cells out of a patient’s bone marrow and editing a gene in the cells in a laboratory, with the modified cells then infused back into the patient after conditioning treatment to prepare the bone marrow. In June 2023, the U.S.
More research is still needed to understand the causes of HS fully. Receiving an accurate and prompt diagnosis of HS is essential for developing a treatment plan and preventing it from worsening. Treatments for Hidradenitis Suppurativa. This may include products with benzoyl peroxide or non-irritating, non-comedogenic cleansers.
When it comes to maintaining healthy, vibrant skin, the choice of skincare products plays a pivotal role. At Academic Alliance in Dermatology, we understand the importance of using products that not only care for your skin on the surface but also work effectively at a cellular level.
The enterprise of delivering life-changing medicines to patients involves a complex ecosystem, and in many ways, three key players reside at the core: drug sponsors, the contract research organizations (CROs) that support them and the clinicalresearch sites directly engaging with patients in the trial.
Managing rosacea can be challenging, but with the right treatments, many people see significant improvements. Here’s a closer look at the top treatments that can help control this condition and why professional guidance is key. Products should be non-irritating, fragrance-free, and designed for sensitive skin.
Though they do positively impact patients’ quality of life and hemodynamic parameters, these treatments — prostacyclin analogs and receptor agonists, phosphodiesterase 5 inhibitors, endothelin-receptor antagonists, and cGMP activators — have shown limited beneficial effects on survival and disease progression.
The PPD clinicalresearch business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. In contrast, study design and product registration are the least likely to be outsourced.
The drug development industry faces rising costs and increasingly complex protocols as top challenges, with 49% of developers citing costs as their primary concern and 39% pointing to protocol complexity as a key hurdle, according to a recent survey of 150 drug developers worldwide by the PPD clinicalresearch business of Thermo Fisher Scientific.
The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinicalresearchers to discuss the latest advancements and challenges in oncology research.
While these conditions cannot be cured, there are treatments available that may lessen the symptoms. In addition, clinicalresearch may provide new information and breakthrough treatments. . Therefore finding treatment options that may help lessen the symptoms is important. . Treatment Options for Pediatric Eczema.
Furthermore, adult eczema is more likely to occur in specific areas of the body, such as: The back of the knee Crooks of the elbow The face The back of the neck Around the eyes Understanding these differences is crucial in developing effective treatment and management strategies for both adult and child eczema.
Despite continuous innovations in the treatment landscape, unmet needs remain. Overall, the number of treatment-emergent adverse events reported was similar between the ponesimod and teriflunomide treated groups, and the majority were mild/moderate and did not warrant treatment discontinuation. vs. 9.4%), nasopharyngitis (19.3%
SH ) submitted its pivotal phase III clinical trial application (IND) of national class I innovative drug Chiauranib to NMPA, for the treatment of Small Cell Lung Cancer (SCLC) as a single agent for the patients after 2nd-line systemic chemotherapy and recurrence afterwards. (Chipscreen Biosciences, Stock Symbol: 688321.SH
QuartzBio’s suite of end-to-end SaaS solutions provides pharmaceutical and biotech clients with a fully connected data ecosystem linking sample, biomarker, and clinical data to improve collaboration, planning and R&D productivity. We are honored to be a part of this journey.” Canada, Europe and Australia.
Common food allergens include: Dairy products Eggs Nuts Soy Wheat Research suggests that up to 30% of children with atopic dermatitis may have food allergies, making it crucial for parents to monitor potential reactions. Skincare: Opt for hypoallergenic products and moisturize regularly to strengthen the skin’s barrier.
Certain skin products. Avoid using scented products, as they may irritate the skin further. If you are unsure which products to use, consult with a dermatologist or doctor. Find a Prurigo Nodularis Clinical Trial at Olympian ClinicalResearch. Rough fabrics like wool or polyester.
Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. IBC membership must include involving two local community members who reside within 50 miles of the research site.
E&C lawmakers grill directors of FDA medical product centers Wednesday’s House E&C Health Subcommittee Hearing featured an extensive grilling of the leaders of FDA’s three medical products centers: CDER, CBER and CDRH. People are then not getting the right treatment. Read AgencyIQ’s analysis of the rule here.]
It broadens recruitment strategies, diversifies the patient population, and expands the study population, thus increasing access to potentially life-saving treatments. These trials increase the chances of success by enabling the early detection of effective treatments in defined populations and focusing efforts on the most promising options.
At Academic Alliance in Dermatology , we believe in providing treatments that enhance natural beauty. These micro-injuries stimulate the skin’s natural healing process, leading to the production of new collagen and elastin. What is Microneedling with PRP? 6 Benefits of Microneedling with PRP 1.
If you suspect you have HS, seeking medical advice for accurate diagnosis and treatment is crucial. Additionally, avoid products with potential irritants like artificial fragrances or dyes. For women, consider alternatives to shaving affected areas, like hair removal creams or laser treatment, to reduce skin irritation.
Read the Pre-print Rare Roundup A seemingly small semantic issue is a major roadblock to develop treatments for rare diseases We’ve spoken often about the goal of repurposing existing drugs to better treat KAND – this is a reality for many families who utilize off-label prescriptions.
It can augment preclinical and clinicalresearch through mechanistic and predictive investigations that would otherwise be impossible. Virtual patients are then generated who can be randomized to one or more cohorts to allow researchers to select treatment options.
Selection of the appropriate design requires holistic consideration of your investigational product(s), patient population(s), and program specifics. Umbrella Studies Umbrella studies evaluate multiple investigational products (IPs) within a single disease. When Are Master Protocols Appropriate?
inhibitor, for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. Commercial supply is expected to be available by early September.
Many of us desire youthful, radiant skin, and microneedling has emerged as a leading treatment option. This innovative treatment is designed to rejuvenate your skin from the inside out, delivering natural, safe, and impressive results for all skin tones and types. This should subside within 24 to 72 hours. Why Choose SkinPen?
We offer several treatment options to help reduce the appearance of age spots and restore your skin’s natural, youthful glow. Ways to Remove Age Spots At Academic Alliance in Dermatology, we specialize in advanced, professional treatments to effectively reduce age spots, ensuring our patients receive the highest standard of care.
Vial | Pros and Cons The unprecedented consequences of the COVID-19 pandemic gave rise to the advent of decentralized clinical trials (DCTs), which are studies that use telemedicine and remote or local healthcare professionals to enable participants to join from different locations. billion and now functions as a subsidiary.
Red meats Dairy products Alcohol Fried foods Citrus fruits Nightshade vegetables Spicy foods Foods To Incorporate in the Psoriasis Diet Just as some foods can trigger inflammation and exacerbate psoriasis symptoms, others might help to calm the immune system and reduce inflammation. Let’s shape the future of psoriasis treatment together.
These challenges not only slow down the development of new treatments but also increase costs and potentially impact patient outcomes. As clinical trials grow more complex and data-intensive, addressing these pain points in data management becomes increasingly crucial for researchers and product teams.
Together with our research partners, BIG conducts landmark, practice-changing trials that can have a significant impact on the lives of women with breast cancer,” sa id David Cameron , Chair of the BIG Executive Board. Adjuvant therapy helps prevent and delay the progression of disease into the later setting.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
69 
Let's personalize your content